About A4Cell
A4Cell is a company based in Madrid (Spain) founded in 2018.. A4Cell has raised $5.4 million across 4 funding rounds from investors including European Union, BeAble Capital and Dreavent Capital. A4Cell offers products and services including CytoCHECK SPAchip® pH green Single-Detection Kit, CytoCHECK SPAchip® Calcium Single-Detection Kit, CytoCHECK SPAchip® OHrad ROS Single-Detection Kit, and CytoTRACK SPAchip® pH Dual-Detection Kit. A4Cell operates in a competitive market with competitors including 10X Genomics, Mission Bio, Cellares, LUMICKS and LevitasBio, among others.
- Headquarter Madrid, Spain
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Arrays For Cell Nanodevices S.L.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.4 M (USD)
in 4 rounds
-
Latest Funding Round
$3.26 M (USD), Series B
Nov 16, 2023
-
Investors
European Union
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of A4Cell
A4Cell offers a comprehensive portfolio of products and services, including CytoCHECK SPAchip® pH green Single-Detection Kit, CytoCHECK SPAchip® Calcium Single-Detection Kit, CytoCHECK SPAchip® OHrad ROS Single-Detection Kit, and CytoTRACK SPAchip® pH Dual-Detection Kit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Monitors intracellular pH in living cells for real-time analysis.
Enables calcium monitoring in cellular signaling pathways.
Detects reactive oxygen species in cells for research purposes.
Facilitates dual pH monitoring in cellular processes.
Unlock access to complete
Funding Insights of A4Cell
A4Cell has successfully raised a total of $5.4M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $3.26 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $3.3M
-
First Round
First Round
(07 Apr 2019)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Series B - A4Cell | Valuation | Dreavent | |
| Apr, 2022 | Amount | Grant - A4Cell | Valuation |
investors |
|
| Dec, 2021 | Amount | Series A - A4Cell | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in A4Cell
A4Cell has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, BeAble Capital and Dreavent Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early stage energy and tech focused VC firm investing primarily in Spain
|
Founded Year | Domain | Location | |
|
Biotech investments are managed by Dreavent Capital for innovation.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by A4Cell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - A4Cell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
A4cell Comparisons
Competitors of A4Cell
A4Cell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Cellares, LUMICKS and LevitasBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| domain | founded_year | HQ Location |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| domain | founded_year | HQ Location |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| domain | founded_year | HQ Location |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
|
| domain | founded_year | HQ Location |
Single-cell imaging platform developed via magnetic levitation technology.
|
|
| domain | founded_year | HQ Location |
An imaging system for single-cell gene analysis is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about A4Cell
When was A4Cell founded?
A4Cell was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is A4Cell located?
A4Cell is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Who is the current CEO of A4Cell?
Elena Rivas is the current CEO of A4Cell.
Is A4Cell a funded company?
A4Cell is a funded company, having raised a total of $5.4M across 4 funding rounds to date. The company's 1st funding round was a Series A of $1.41M, raised on Apr 07, 2019.
What does A4Cell do?
A4Cell was established in 2018 in Madrid, Spain, within the biotechnology sector. Tools for examining live single cells are developed, including the SPAchip Technology. Cell behavior, physiology, and biomolecular interactions are analyzed through this approach. Responses from individual cells are tracked over extended periods. Research applications in cell monitoring are supported across operations.
Who are the top competitors of A4Cell?
A4Cell's top competitors include 10X Genomics, Mission Bio and Cellares.
What products or services does A4Cell offer?
A4Cell offers CytoCHECK SPAchip® pH green Single-Detection Kit, CytoCHECK SPAchip® Calcium Single-Detection Kit, CytoCHECK SPAchip® OHrad ROS Single-Detection Kit, and CytoTRACK SPAchip® pH Dual-Detection Kit.
Who are A4Cell's investors?
A4Cell has 5 investors. Key investors include European Union, BeAble Capital, Dreavent Capital, Innvierte Economia Sostenible Sicc Sme, and Ideas de bomberossl.